These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6164107)

  • 1. [CCNU, bleomycin, and vincristine (vinblastine) combination therapy in the treatment of resistant lymphoma (author's transl)].
    García López J; Diumenjo MC; Argüelles MV; Marín P; Grañena A; Montserrat E; Rozman C
    Sangre (Barc); 1980; 25(6):1014-21. PubMed ID: 6164107
    [No Abstract]   [Full Text] [Related]  

  • 2. [Combination chemotherapy in advanced malignant lymphoma with bleomycin, vincristine, adriamycin and prednisolone (author's transl)].
    Kurita S; Kamei Y; Murakami M; Oyama A; Goto T; Fukushima M; Ota K
    Rinsho Ketsueki; 1982 Jan; 23(1):61-7. PubMed ID: 6178855
    [No Abstract]   [Full Text] [Related]  

  • 3. Lomustine (chloroethylnitrosourea [CCNU]), ifosfamide, bleomycin, vincristine, and cisplatin (CIBO-P) is an effective regimen for patients with poor prognostic refractory or multiple disease recurrent aggressive non-Hodgkin lymphoma.
    Musolino A; Perrone MA; Michiara M; Delnevo D; Franciosi V; Di Blasio B; Ceci G; Camisa R; Ardizzoni A; Cocconi G
    Cancer; 2005 May; 103(10):2109-17. PubMed ID: 15803492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized study for the treatment of adult advanced Hodgkin's disease: mechlorethamine, vincristine, procarbazine, and prednisone (MOPP) versus lomustine, vinblastine, and prednisone.
    Liebman HA; Hum GJ; Sheehan WW; Ryden VM; Bateman JR
    Cancer Treat Rep; 1983 May; 67(5):413-9. PubMed ID: 6342771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Chemotherapy of MOPP and C-MOPP resistant cases of malignant lymphoma. (A preliminary report) (author's transl)].
    Kolarić K; Tomek R; Roth A
    Lijec Vjesn; 1980 Jun; 102(6):306-9. PubMed ID: 7453477
    [No Abstract]   [Full Text] [Related]  

  • 6. MOPPEBVCAD chemotherapy with limited and conditioned radiotherapy in advanced Hodgkin's lymphoma: 10-year results, late toxicity, and second tumors.
    Gobbi PG; Broglia C; Levis A; La Sala A; Valentino F; Chisesi T; Sacchi S; Corbella F; Cavanna L; Iannitto E; Pavone V; Molica S; Corazza GR; Federico M
    Clin Cancer Res; 2006 Jan; 12(2):529-35. PubMed ID: 16428496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ABVD versus modified stanford V versus MOPPEBVCAD with optional and limited radiotherapy in intermediate- and advanced-stage Hodgkin's lymphoma: final results of a multicenter randomized trial by the Intergruppo Italiano Linfomi.
    Gobbi PG; Levis A; Chisesi T; Broglia C; Vitolo U; Stelitano C; Pavone V; Cavanna L; Santini G; Merli F; Liberati M; Baldini L; Deliliers GL; Angelucci E; Bordonaro R; Federico M;
    J Clin Oncol; 2005 Dec; 23(36):9198-207. PubMed ID: 16172458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hybrid chemotherapy consisting of cyclophosphamide, vincristine, procarbazine, prednisone, doxorubicin, bleomycin, and vinblastine (C-MOPP/ABV) as first-line treatment for patients with advanced Hodgkin disease.
    Montoto S; Camós M; López-Guillermo A; Bosch F; Cervantes F; Blandé J; Esteve J; Cobo F; Nomdedeu B; Campo E; Montserrat E
    Cancer; 2000 May; 88(9):2142-8. PubMed ID: 10813727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Re-evaluation of the combination of CCNU, vincristine, and bleomycin in the treatment of malignant disseminated melanoma.
    Abele R; Bernheim J; Cumps E; Buyse M; Kenis Y
    Cancer Treat Rep; 1981; 65(5-6):505-6. PubMed ID: 6165474
    [No Abstract]   [Full Text] [Related]  

  • 10. The cure of Hodgkin's disease with drugs.
    DeVita VT; Hubbard SM; Moxley JH
    Adv Intern Med; 1983; 28():277-302. PubMed ID: 6188346
    [No Abstract]   [Full Text] [Related]  

  • 11. [A study of two protocols of multiple chemotherapy in small round cell tumours of the lung (author's transl)].
    Israël L; Breau JL; Depierre A; Choffel C; Lemarié E; Battesti JP
    Rev Fr Mal Respir; 1981; 9(2):123-31. PubMed ID: 6166970
    [No Abstract]   [Full Text] [Related]  

  • 12. [Long-term responders of non-Hodgkin's lymphoma: patients treated with combination chemotherapy].
    Nishihara R; Ohnoshi T; Oka A; Hayashi K; Sato M; Ueoka H; Yasuoka M; Sando Y; Kimura I
    Rinsho Ketsueki; 1982 Aug; 23(8):1192-7. PubMed ID: 6183469
    [No Abstract]   [Full Text] [Related]  

  • 13. [Lymphomas. Treatment of malignant lymphomas. Current observations and future prospects].
    Klastersky J
    Rev Med Brux; 1982 Apr; 3(4):223-34. PubMed ID: 6178138
    [No Abstract]   [Full Text] [Related]  

  • 14. [Results with the cytostatic agent bleomycin in tumour therapy (author's transl)].
    Baumgartner G
    Wien Klin Wochenschr; 1973 Oct; 85(42):686-92. PubMed ID: 4128921
    [No Abstract]   [Full Text] [Related]  

  • 15. [A case of leukemic non-Hodgkin lymphoma with DIC, which was induced into complete remission by DCOP-therapy (author's transl)].
    Nakanishi S; Yamazaki H; Kono Y; Nakata T; Nishio A; Haruyama H; Katsuki A; Nakagawa M; Sugishima K; Ijichi H; Isemura T
    Rinsho Ketsueki; 1981 Jun; 22(6):896-902. PubMed ID: 7334616
    [No Abstract]   [Full Text] [Related]  

  • 16. [Therapeutic effect of combined administration of four drugs; vincristine, bleomycin, cyclophosphamide and prednisolone for patients with malignant lymphoma (author's transl)].
    Kimura I; Ohnoshi T; Nakata Y; Oka A; Hiraki S; Urabe Y; Fujii M; Hayashi K; Sato M; Kataoka M; Nishihara R; Terao S; Mito T; Tanaka T
    Rinsho Ketsueki; 1980 Jun; 21(6):792-800. PubMed ID: 6162040
    [No Abstract]   [Full Text] [Related]  

  • 17. [Cyclophosphamide, adriamycin, vincristine, bleomycin and prednisolone (CHOP-Bleo) combination chemotherapy for advanced non-Hodgkin's lymphoma].
    Sampi K; Honda T; Hattori M; Takayama S
    Gan To Kagaku Ryoho; 1983 May; 10(5):1266-71. PubMed ID: 6191677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Chemotherapy of generalized forms of lymphogranulomatosis with vinblastine and vincristine].
    Danova LA
    Vopr Onkol; 1975; 21(7):43-8. PubMed ID: 1216789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of recurrent lymphomas with vincristine, BCNU, doxorubicin, and prednisone (VBAP): a Southwest Oncology Group Study.
    Weick JK; Jones SE; Haut A; Fisher R; Dixon D
    Cancer Treat Rep; 1981; 65(7-8):611-4. PubMed ID: 6166373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [B-DOPA chemotherapy associated with local radiotherapy in children with malignant lymphoma].
    Armata J; Legutko L
    Pol Tyg Lek; 1982 Apr; 37(7):193-5. PubMed ID: 6180419
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.